Lucinda Sanchez Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2715 Saint Andrews Loop Ste D, Pasco, WA 99301 Phone: 509-575-4084 |
Mrs. Heather Cooper, LICSW, CMHS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9825 Sandifur Pkwy Ste D, Pasco, WA 99301 Phone: 509-491-0991 |
Jacob R Spanjer Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 715 W Court St, 2nd Floor, Pasco, WA 99301 Phone: 509-545-6505 |
Jan Michael, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 6304 W Richardson Rd, Pasco, WA 99301 Phone: 509-851-3280 Fax: 509-349-5069 |
Mr. John Jason Chastain, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9825 Sandifur Pkwy Ste D, Pasco, WA 99301 Phone: 509-531-6698 Fax: 509-402-1176 |
Jessica Reed Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2715 Saint Andrews Loop Ste D, Pasco, WA 99301 Phone: 509-575-4084 |
Mrs. Kathryn Joy Fox, MSW, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 9825 Sandifur Pkwy Ste D, Pasco, WA 99301 Phone: 509-528-9593 Fax: 509-785-5321 |
Pamela May Olson, MSW, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5109 Monrovia Ln, Pasco, WA 99301 Phone: 509-308-1314 |
News Archive
It is already known that substance misuse is a common problem on acute psychiatric wards in the UK, and leads to disruption for patients and staff alike. Whilst having an agreed policy on how to deal with ward substance misuse might be expected to help guide staff, evidence suggests that existing policies are often inconsistent in application.
A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
IntelliCell BioSciences, Inc. announced today that it has filed a patent application for a new mechanical method to separate stromal vascular fraction (SVF) from the blood vessels in adipose tissue (fat) to be used clinically in regenerative medicine.
› Verified 2 days ago